Status:
COMPLETED
Risk Prediction of Carotid Endarterectomy by Vascular Ultrasound Evaluation
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Stroke
Eligibility:
All Genders
18-85 years
Brief Summary
Carotid endarterectomy (CEA) is one of the surgical treatment methods for the reconstruction of arterial stenosis or occlusion. Perioperative stroke, cerebral hemorrhage,hyperperfusion syndrome and de...
Detailed Description
Subjects: In this study, a total of 600-800 patients with severe carotid artery stenosis or occlusion who scheduled for CEA are recruited. Data collection: 1. The plaque characteristics, stenosis de...
Eligibility Criteria
Inclusion
- Patients with carotid artery severe (70-99%) stenosis or occlusion diagnosed by color duplex flow imaging (CDFI) and confirmed by CT angiography (CTA) or digital subtraction angiography (DSA).
- Patient has the indications for carotid artery stenting or CEA according to the guidelines published by the Stroke Prevention Engineering Committee, the National Health Commission of China.
- MRI and CT were applicated pre- and postoperation.
Exclusion
- Patients with non-atherosclerotic carotid artery stenosis or occlusion, such as dissection, aneurysm, arteritis, cardiac embolism, et al.
- Lack of any imaging evaluation results, such as ultrasound, MRI or CT.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
1498 Patients enrolled
Trial Details
Trial ID
NCT03785626
Start Date
January 1 2019
End Date
December 31 2021
Last Update
July 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053